These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 3044094
21. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuñiga R, Magaret AS, Wald A, Corey L, Celum C. J Infect Dis; 2007 Nov 15; 196(10):1500-8. PubMed ID: 18008230 [Abstract] [Full Text] [Related]
22. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy. Eisen D, Essell J, Broun ER, Sigmund D, DeVoe M. Bone Marrow Transplant; 2003 Jan 15; 31(1):51-5. PubMed ID: 12621507 [Abstract] [Full Text] [Related]
23. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. Stránská R, Schuurman R, Nienhuis E, Goedegebuure IW, Polman M, Weel JF, Wertheim-Van Dillen PM, Berkhout RJ, van Loon AM. J Clin Virol; 2005 Jan 15; 32(1):7-18. PubMed ID: 15572000 [Abstract] [Full Text] [Related]
24. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients. Levin MJ, Bacon TH, Leary JJ. Clin Infect Dis; 2004 Nov 01; 39 Suppl 5():S248-57. PubMed ID: 15494896 [Abstract] [Full Text] [Related]
25. [Follow-up and prognosis of herpes simplex encephalitis. Observations on 57 patients between 1960 and 1987]. Huber M, Ziffling P, Heucke T, Heiss WD. Med Klin (Munich); 1989 Jun 15; 84(6):273-5. PubMed ID: 2755410 [Abstract] [Full Text] [Related]
26. Studies in the prophylaxis of herpes infections in severely immunocompromised patients using acyclovir. Prentice HG, Hann IM. Schweiz Med Wochenschr Suppl; 1983 Jun 15; 14():26-9. PubMed ID: 6361988 [Abstract] [Full Text] [Related]
28. A nurse practitioner's guide to the management of herpes simplex virus-1 in children. Drugge JM, Allen PJ. Pediatr Nurs; 2008 Oct 15; 34(4):310-8. PubMed ID: 18814565 [Abstract] [Full Text] [Related]
29. Acyclovir for herpes simplex infections. Moore JA, Duke HM. Am Fam Physician; 1984 Feb 15; 29(2):187-90. PubMed ID: 6702527 [Abstract] [Full Text] [Related]
30. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome. Ziyaeyan M, Alborzi A, Japoni A, Kadivar M, Davarpanah MA, Pourabbas B, Abassian A. Int J Dermatol; 2007 Dec 15; 46(12):1263-6. PubMed ID: 18173520 [Abstract] [Full Text] [Related]
31. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial. Lin L, Chen XS, Cui PG, Wang JB, Guo ZP, Lu NZ, Bi ZG, Jia H, Yang XY, Topical Penciclovir Clinical Study Group. J Dermatolog Treat; 2002 Jun 15; 13(2):67-72. PubMed ID: 12060504 [Abstract] [Full Text] [Related]
32. Acyclovir and renal transplantation. Pettersson E, Eklund B, Höckerstedt K, Salmela K, Ahonen J. Scand J Infect Dis Suppl; 1985 Jun 15; 47():145-8. PubMed ID: 3912970 [Abstract] [Full Text] [Related]
33. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L. J Infect Dis; 2002 Dec 15; 186(12):1718-25. PubMed ID: 12447756 [Abstract] [Full Text] [Related]
34. Systemic antivirals in herpesvirus infections. Sasadeusz JJ, Sacks SL. Dermatol Clin; 1993 Jan 15; 11(1):171-85. PubMed ID: 8382122 [Abstract] [Full Text] [Related]
35. Treatment and prevention of virus infections in immunosuppressed patients. Lietman PS, Saral R. Antiviral Res; 1985 Jan 15; Suppl 1():241-50. PubMed ID: 3002259 [No Abstract] [Full Text] [Related]
36. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts. Engelhard D, Morag A, Or R, Naparstek E, Cividalli G, Ruchlemer R, Aker M, Maayan S, Slavin S. Isr J Med Sci; 1988 Mar 15; 24(3):145-50. PubMed ID: 3286577 [Abstract] [Full Text] [Related]
37. Chronic herpes simplex scleritis: characterization of 9 cases of an underrecognized clinical entity. Bhat PV, Jakobiec FA, Kurbanyan K, Zhao T, Foster CS. Am J Ophthalmol; 2009 Nov 15; 148(5):779-789.e2. PubMed ID: 19674728 [Abstract] [Full Text] [Related]
38. Interim summary of mortality in herpes simplex encephalitis and neonatal herpes simplex virus infections: vidarabine versus acyclovir. Whitley RJ. J Antimicrob Chemother; 1983 Sep 15; 12 Suppl B():105-12. PubMed ID: 6355046 [Abstract] [Full Text] [Related]
39. Herpes simplex virus infections of the central nervous system. A review. Whitley RJ. Am J Med; 1988 Aug 29; 85(2A):61-7. PubMed ID: 3044095 [Abstract] [Full Text] [Related]
40. Drug therapy. Treatment of herpesvirus infections. Hirsch MS, Schooley RT. N Engl J Med; 1983 Oct 27; 309(17):1034-9. PubMed ID: 6312313 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]